Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenocarcinoma
University of Heidelberg publishes research in adenocarcinoma
March 25th, 2008
According to recent research from Heidelberg, Germany, "The value of re-exploration for pancreatic ductal adenocarcinoma after the initial diagnosis of unresectability is unclear. In this study, we analyzed 33 patients who were re-explored after an initial diagnosis of unresectability." "At the time of reoperation, a resectable tumor was found in 18 patients: therefore, 15 pancreaticoduodenectomies, two total pancreatectomies and one left resection were performed with three vascular resections. Morbidity and mortality rates for the cohort were 6/33 and 1/33, without significant differences between resectable and nonresectable patients. Length of stay, duration of...
Source: Cancer Weekly (2008-03-25)
|
